Compare HRZN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRZN | OSUR |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.1M | 275.4M |
| IPO Year | N/A | 2000 |
| Metric | HRZN | OSUR |
|---|---|---|
| Price | $4.41 | $4.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $6.50 | $3.00 |
| AVG Volume (30 Days) | ★ 869.5K | 740.6K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 33.85% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $12.25 | $4.48 |
| Revenue Next Year | $22.53 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.80 | $2.08 |
| 52 Week High | $8.46 | $4.58 |
| Indicator | HRZN | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 64.92 |
| Support Level | $3.96 | $2.84 |
| Resistance Level | $4.73 | $4.58 |
| Average True Range (ATR) | 0.19 | 0.21 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 52.07 | 76.72 |
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.